Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mechanisms restricting hepatitis B virus cross-species transmission.

mBio·2026
Same author

Metadomain and metaloop genome interactions in mammalian T cells.

Cell reports·2026
Same author

EIF4H and YBX1 are essential host factors for hepatitis E virus replication and pathogenesis.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Metadomain and metaloop genome interactions in mammalian T cells.

bioRxiv : the preprint server for biology·2025
Same author

Receptor transporter protein 4 (RTP4)-mediated repression of hepatitis C virus replication in mouse cells.

PLoS pathogens·2025
Same author

Assessment of hepatitis C virus permissiveness in iteratively genetically humanized mice.

Journal of virology·2025

Related Experiment Video

Updated: May 26, 2026

Establishment of the Dual Humanized TK-NOG Mouse Model for HIV-associated Liver Pathogenesis
10:12

Establishment of the Dual Humanized TK-NOG Mouse Model for HIV-associated Liver Pathogenesis

Published on: September 11, 2019

Deconstructing hepatitis C virus infection in humanized mice.

Marcus Dorner1, Alexander Ploss

  • 1Center for the Study of Hepatitis C, Laboratory for Virology and Infectious Disease, The Rockefeller University, New York, New York, USA.

Annals of the New York Academy of Sciences
|January 4, 2012
PubMed
Summary

Hepatitis C virus (HCV) infection poses a significant global health challenge. New small-animal models are crucial for advancing HCV therapeutics and vaccine development.

More Related Videos

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
09:03

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

Published on: February 3, 2012

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors
16:49

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors

Published on: July 16, 2012

Related Experiment Videos

Last Updated: May 26, 2026

Establishment of the Dual Humanized TK-NOG Mouse Model for HIV-associated Liver Pathogenesis
10:12

Establishment of the Dual Humanized TK-NOG Mouse Model for HIV-associated Liver Pathogenesis

Published on: September 11, 2019

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
09:03

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

Published on: February 3, 2012

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors
16:49

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors

Published on: July 16, 2012

Area of Science:

  • Virology
  • Infectious Diseases
  • Animal Models

Background:

  • Hepatitis C virus (HCV) represents a substantial global health burden.
  • Current treatment options for HCV are effective but can be costly and have side effects.
  • The development of a curative vaccine remains a critical unmet need.

Purpose of the Study:

  • To highlight the importance of novel small-animal models for Hepatitis C virus research.
  • To emphasize the potential of these models in accelerating the discovery of new antiviral therapies.
  • To underscore their role in facilitating the development of an effective HCV vaccine.

Main Methods:

  • Review of existing literature on small-animal models for Hepatitis C virus.
  • Analysis of the limitations of current models in replicating human HCV infection.
  • Discussion of emerging small-animal models and their potential applications.

Main Results:

  • Small-animal models are essential for studying HCV pathogenesis and immune responses.
  • These models provide a platform for high-throughput screening of antiviral compounds.
  • Advancements in small-animal models are critical for preclinical testing of vaccine candidates.

Conclusions:

  • Novel small-animal models are indispensable tools for advancing Hepatitis C virus research.
  • Accelerated development of effective therapeutics and a vaccine is anticipated with improved models.
  • Investment in and utilization of these models will significantly impact the fight against HCV.